[Articles] Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study
The Lancet Oncology
This is the first study of cancer outcome to integrate DNA-based and microenvironment-based failure indices to predict patient outcome. Patients exhibiting these aggressive features after biopsy should be entered into treatment intensification trials.
Original Article: http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(14)71021-6/abstract?rss=yes
No comments:
Post a Comment